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Over 90% of adults are carriers of latent human herpesvirus 6 (HHV-6). It is primarily a non-
pathogenic infection, but can cause roseola infantum in young children and more severe disease in 
immunocompromised individuals such as transplant recipients. Active HHV-6 infection, resulting 
from reactivation of the latent virus, is generally detected by polymerase chain reaction (PCR) 
testing on plasma, serum, or whole blood. The latent HHV-6 genome exists as an extrachromosomal 
circular episome, however around 1% of the population possess an integrated copy of the HHV-6 
genome in all of their cells. This can confound clinicians when attempting to diagnose active HHV-6 
infection, and the result is that potentially toxic antiviral medication can be mistakenly administered 
to transplant patients without active HHV-6 infection who possess the integrated copy. A new 
method of detecting chromosomally integrated HHV-6 (ciHHV-6) in patient samples has recently 
been developed by Dr. Keith Jerome's Laboratory (Vaccine and Infectious Disease Division). 
Through the use of a precise quantitative PCR called droplet digital PCR (ddPCR), ciHHV-6 can be 
identified in patients with 100% sensitivity. The study was recently published in Clinical Chemistry. 
Individuals with ciHHV-6 always exhibit high viral loads, which can be mistaken for actively 
replicating HHV-6. In fact, it has been shown that ciHHV-6 cannot be distinguished from active 
infection based solely on a plasma quantitative PCR (qPCR) for HHV-6. Currently, confirmation of 
ciHHV-6 requires fluorescence in situ hybridization or PCR testing of hair follicle cells, neither of 
which is a common assay in molecular diagnostics laboratories. The ability to accurately detect 
ciHHV-6 in patients using a standard laboratory assay would assist tremendously in preventing 
misdiagnoses and the unnecessary administration of drugs with severe side effects. 
The newly developed droplet digital PCR assay provides a method for quantitating a DNA sequence 
of interest (e.g., HHV-6) with a very high degree of precision. This is accomplished by generating a 
large number of droplets from a test sample, which individually supply a digital readout (either yes or 
no) for the presence of the DNA sequence in each droplet. Software analysis on the number of 
positive droplets provides an exact quantitation of the specific DNA molecules without the need for a 
standard curve. Additionally, by duplexing the assay to also measure a chromosomal gene, the ratio 
of viral DNA copies per cell can be accurately determined. 
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Researchers in the Jerome Lab first utilized the new technique to study the virus per cell ratio 
detected from a cultured cell line possessing a single integrated copy of ciHHV-6. They found that 
the HHV-6 per cell ratio consistently had a value of about 1 (0.96 ± 0.03). Furthermore, whole blood 
samples from patients with known ciHHV-6 also showed virus per cell ratios to be near 1. They also 
confirmed that their test could be applicable to plasma samples, which contain cellular DNA, albeit in 
low amounts. They established a virus per cell cutoff range of 0.56–1.78 for identifying ciHHV-6. By 
these criteria, the assay showed 100% sensitivity, meaning that no sample from a ciHHV-6 patient 
was incorrectly identified as negative, as well as 82% specificity for ciHHV-6. 
"This assay is going to be a big deal for our transplant patients who have ciHHV-6," said Jerome. 
"Previously, they've often been misdiagnosed with active HHV-6 disease, exposing them to 
unnecessary antivirals and ending their diagnostic workup too soon. Now we have a way to identify 
these patients and be sure they're getting appropriate care." The high accuracy of the test at 
identifying ciHHV-6 patients makes it a strong candidate for broad usage in molecular virology 
diagnostic labs around the world. Jerome envisions this assay to have great potential. "We hope this 
test will see quick adoption elsewhere so that advances from here in Seattle can soon be available 
worldwide." 
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Image provided by Dr. Ruth Hall Sedlak. 
Droplet digital PCR (ddPCR) can accurately identify ciHHV-6 patients while plasma qPCR oftentimes 
cannot distinguish between ciHHV-6 and acute HHV-6 infection. 
 
